Navigation Links
Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase
Date:5/21/2008

LOS ANGELES, May 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that revenues for the first quarter of 2008, ended March 31, totaled $1.43 million. Revenues from the Company's primary umbilical cord blood storage business increased 10 percent while reducing marketing and advertising costs. Overall revenues decreased because of a change in business strategies at the Company's advertising subsidiary, Rainmakers International, to focus on low cost, high volume, annuity based advertising.

"While there are areas to improve in the quarter, we are especially pleased that Gross Profit increased from 35 percent of revenues to 45 percent, because a significantly higher proportion of revenues are coming from the higher margin umbilical cord blood processing and storage business," said Matthew Schissler, CEO, Cord Blood America. "We are confident that our continued focus on recurring revenue models for both Rain and the umbilical cord blood business will pay dividends in the near future."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at http:/
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Teen Blood Donors More Prone to Complications
2. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
3. Many Diabetics Dont Get Necessary Blood Pressure Treatment
4. Blood-clotting protein modified for people with hard-to-treat hemophilia
5. Blood test for lung cancer may be possible
6. Calpis AmealPeptide lowers blood pressure in 2 placebo-controlled trials
7. Researchers expand natural killer cells in cord blood to fight leukemia
8. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
9. Blood Test Helps Docs Assess Breast Cancer Treatment
10. Study suggests blood test can help improve treatment outcomes for breast cancer patients
11. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2Gentiva Reports Second Quarter 2009 Results 53196 1Gentiva Reports Second Quarter 2009 Results 53196 2Gentiva Reports Second Quarter 2009 Results 53196 3Gentiva Reports Second Quarter 2009 Results 53196 4Gentiva Reports Second Quarter 2009 Results 53196 5Gentiva Reports Second Quarter 2009 Results 53196 6Gentiva Reports Second Quarter 2009 Results 53196 7Gentiva Reports Second Quarter 2009 Results 53196 8Gentiva Reports Second Quarter 2009 Results 53196 9Gentiva Reports Second Quarter 2009 Results 53196 10Gentiva Reports Second Quarter 2009 Results 53196 11Gentiva Reports Second Quarter 2009 Results 53196 12Gentiva Reports Second Quarter 2009 Results 53196 13Gentiva Reports Second Quarter 2009 Results 53196 14Gentiva Reports Second Quarter 2009 Results 53196 15Gentiva Reports Second Quarter 2009 Results 53196 16BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 1BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 2BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 3BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 4BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 5BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 6BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 7BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 8BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 9Caliper Life Sciences Reports Second Quarter 2009 Results 13273 1Caliper Life Sciences Reports Second Quarter 2009 Results 13273 2Caliper Life Sciences Reports Second Quarter 2009 Results 13273 3Caliper Life Sciences Reports Second Quarter 2009 Results 13273 4Caliper Life Sciences Reports Second Quarter 2009 Results 13273 5Caliper Life Sciences Reports Second Quarter 2009 Results 13273 6Caliper Life Sciences Reports Second Quarter 2009 Results 13273 7Caliper Life Sciences Reports Second Quarter 2009 Results 13273 8Caliper Life Sciences Reports Second Quarter 2009 Results 13273 9Caliper Life Sciences Reports Second Quarter 2009 Results 13273 10